日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

单次与重复静脉注射溶瘤呼肠孤病毒:对肝细胞癌免疫调节和合理化治疗方案安排的影响

Scott, Karen J; West, Emma J; Brownlie, Rebecca J; Ismail, Fay; Ralph, Christy; Heineman, Thomas; Coffey, Matt; Melcher, Alan A; Taylor, Alison; Papa, Salvatore; Samson, Adel

Early adoption of image-guided histotripsy therapy in interventional oncology: challenges and opportunities in the United Kingdom

影像引导组织碎裂疗法在介入肿瘤学中的早期应用:英国面临的挑战和机遇

Ng, Helen Hoi Lam; Chan, Vinson Wai-Shun; Howell, Lewis; Shiwani, Taha; Zhong, Jim; Brandon, Jacqueline; Samson, Adel; Chandler, James; McLaughlan, James; Wah, Tze Min

RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)

RP1联合Nivolumab治疗晚期抗PD-1治疗失败的黑色素瘤(IGNYTE)

Wong, Michael K; Milhem, Mohammed M; Sacco, Joseph J; Michels, Judith; In, Gino K; Muñoz Couselo, Eva; Schadendorf, Dirk; Beasley, Georgia M; Niu, Jiaxin; Chmielowski, Bartosz; Wise-Draper, Trisha M; Bowles, Tawnya Lynn; Tsai, Katy K; Lebbé, Céleste; Gaudy-Marqueste, Caroline; Middleton, Mark R; Skolariki, Aglaia; Samson, Adel; Chesney, Jason A; VanderWalde, Ari M; Zakharia, Yousef; Harrington, Kevin J; Appleton, Elizabeth; Bommareddy, Praveen K; Zhu, Junhong; Viana, Marcus; Hou, Jeannie W; Coffin, Robert S; Robert, Caroline

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

初步验证基于机器学习的肿瘤免疫浸润评估方法作为阿特珠单抗联合贝伐珠单抗治疗肝细胞癌患者预后预测指标的有效性

Scheiner, Bernhard; Lombardi, Pasquale; D'Alessio, Antonio; Kim, Gwangil; Tafavvoghi, Masoud; Petrenko, Oleksandr; Goldin, Robert D; Fulgenzi, Claudia A M; Torkpour, Aria; Balcar, Lorenz; Mauri, Francesco A; Pomej, Katharina; Himmelsbach, Vera; Barsch, Maryam; Celsa, Ciro; Cabibbo, Giuseppe; Cheon, Jaekyung; Krall, Anja; Hucke, Florian; Di Tommaso, Luca; Bernasconi, Monica; Rimassa, Lorenza; Samson, Adel; Stefanini, Bernardo; Mozayani, Behrang; Trauner, Michael; Lackner, Carolin; Stauber, Rudolf; Vasuri, Francesco; Piscaglia, Fabio; Bengsch, Bertram; Finkelmeier, Fabian; Peck-Radosavljevic, Markus; Rasmussen Busund, Lill-Tove; Marafioti, Teresa; Rahbari, Mohammad; Heikenwalder, Mathias; Pinter, Matthias; Chon, Hong Jae; Rakaee, Mehrdad; Pinato, David J

A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

一项 I 期临床试验,研究肝动脉内递送 TG6002 与口服 5-氟胞胞嘧啶联合治疗以肝脏转移为主的结直肠癌患者的疗效

West Emma J, Sadoun Alain, Bendjama Kaidre, Erbs Philippe, Smolenschi Cristina, Cassier Philippe A, de Baere Thierry, Sainte-Croix Sophie, Brandely Maud, Melcher Alan A, Ismail Fay, Scott Karen J, Bennett Angela, Banks Emma, Gasior Ewa, Kent Sarah, Kurzawa Marta, Hammond Christopher, Patel Jai V, Collinson Fiona J, Twelves Chris, Anthoney D Alan, Swinson Dan, Samson Adel

ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

ALBI分级能够对出血事件进行风险分层,并改善接受阿特珠单抗和贝伐珠单抗治疗的晚期肝细胞癌患者的预后预测。

Stefanini, Bernardo; Fulgenzi, Claudia Angela Maria; Scheiner, Bernhard; Korolewicz, James; Cheon, Jaekyung; Nishida, Naoshi; Ang, Celina; Marron, Thomas U; Wu, Y Linda; Saeed, Anwaar; Wietharn, Brooke; Rimassa, Lorenza; Pirozzi, Angelo; Cammarota, Antonella; Pressiani, Tiziana; Pinter, Matthias; Balcar, Lorenz; Huang, Yi-Hsiang; Mehan, Aman; Phen, Samuel; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Samson, Adel; Galle, Peter R; Kudo, Masatoshi; Manfredi, Giulia Francesca; Celsa, Ciro; Awosika, Nichola; Cortellini, Alessio; Singal, Amit G; Sharma, Rohini; Chon, Hong Jae; Tovoli, Francesco; Piscaglia, Fabio; Pinato, David James; D'Alessio, Antonio

Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors

一项针对晚期实体瘤患者的重组减毒溶瘤病毒 MEDI5395 (NDV-GM-CSF) 的 I 期研究,该病毒采用全身给药方式与度伐利尤单抗联合给药。

Davar, Diwakar; Carneiro, Benedito A; Dy, Grace K; Sheth, Siddharth; Borad, Mitesh J; Harrington, Kevin J; Patel, Sandip P; Galanis, Evanthia; Samson, Adel; Agrawal, Sonia; Chen, Zhongying; Fan, Chunling; Gong, Maozhen; Burton, Jenny; Tu, Eric; Durham, Nicholas; Laubscher, Kevin; Arnaldez, Fernanda; Zamarin, Dmitriy

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

一项关于肝细胞癌免疫疗法疗效和安全性性别差异的荟萃分析和真实世界队列研究

Balcar, Lorenz; Scheiner, Bernhard; Fulgenzi, Claudia Angela Maria; D'Alessio, Antonio; Pomej, Katharina; Roig, Marta Bofill; Meyer, Elias Laurin; Che, Jaekyung; Nishida, Naoshi; Lee, Pei-Chang; Wu, Linda; Ang, Celina; Krall, Anja; Saeed, Anwaar; Stefanini, Bernardo; Cammarota, Antonella; Pressiani, Tiziana; Abugabal, Yehia I; Chamseddine, Shadi; Wietharn, Brooke; Parisi, Alessandro; Huang, Yi-Hsiang; Phen, Samuel; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; von Felden, Johann; Schulze, Kornelius; Silletta, Marianna; Trauner, Michael; Samson, Adel; Wege, Henning; Piscaglia, Fabio; Galle, Peter R; Stauber, Rudolf; Kudo, Masatoshi; Singal, Amit G; Itani, Aleena; Ulahannan, Susanna V; Parikh, Neehar D; Cortellini, Alessio; Kaseb, Ahmed; Rimassa, Lorenza; Chon, Hong Jae; Pinato, David J; Pinter, Matthias

E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer

E7介导的miR-203抑制促进HPV阳性宫颈癌细胞中LASP1依赖性增殖

Patterson, Molly R; Meijers, Aniek S; Ryder, Emma L; Scarth, James A; Evans, Debra; Turner, Amy L; Wasson, Christopher W; Darell, Janne E; Theobald, Daisy; Cogan, Joseph; James, Claire D; Wang, Miao; Ladbury, John E; Morgan, Iain M; Samson, Adel; Morgan, Ethan L; Macdonald, Andrew

Case report: Successful treatment of a patient undergoing haemodialysis with multifocal hepatocellular carcinoma using atezolizumab and bevacizumab

病例报告:使用阿特珠单抗和贝伐珠单抗成功治疗一例接受血液透析的多灶性肝细胞癌患者

Abraham, Shalin; Samson, Adel